Carpmaels & Ransford has once again been named as one of Europe’s Leading Patent Law Firms in the Financial Times annual rankings.
The firm was also awarded a gold ranking in the category of Chemistry & Pharmacy, and a silver rating for Biotechnology, Food & Healthcare.
The publication ranks Europe’s most highly regarded firms for patent prosecution and patent strategy consultation based on recommendations from clients and peers, with the most frequently recommended firms attaining gold ratings.
The rankings follow Carpmaels & Ransford’s recent success at the LMG Life Sciences Awards 2025 EMEA, where the firm took home Patent Litigation Firm of the Year: Biologics & Biosimilars, and SPC Litigation Firm of the Year, along with two individual partner awards.
